Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylene Chloride SCHEMBL27870524 | 0.96 | — | — | |
| SCHEMBL17961618 | 0.92 | KIF11 (0.36) | — | |
| SCHEMBL28304175 | 0.87 | CHRM2 (0.31) | — | |
| SCHEMBL5663554 | 0.83 | CHRM2 (0.31) | — | |
| SCHEMBL8135345 | 0.83 | CHRM3 (0.35) | — | |
| SCHEMBL28832854 | 0.82 | — | — | |
| SCHEMBL28576238 | 0.78 | TSHR (0.33) | TSHR | |
| SCHEMBL5185260 | 0.73 | — | — | |
| Phenol SCHEMBL28164302 | 0.68 | PDE4A (0.33) | — | |
| Acetonitrile SCHEMBL28641911 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-09 | — | — | US | claimed |
| EP-4286393-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | Daiichi Sankyo Company, Limited (JP) | 2023-12-06 | — | — | EP | claimed |
| WO-2022163846-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | 第一三共株式会社 | 2022-08-04 | — | — | WO | claimed |
| CN-105381844-B | The tooth-like material-pulverizing device of one kind rotation | 徐州工程学院 | 2017-10-27 | — | — | CN | claimed |
| CN-105399263-B | The complete set of equipments and its minimizing technology of ferromanganese ion are removed in a kind of mine water | 徐州市城区水资源管理处 | 2017-08-15 | — | — | CN | claimed |
| CN-105399263-A | Complete equipment for removing iron ions and manganese ions from pit water and removal method thereof | XUZHOU CITY URBAN WATER RESOURCE MAN OFFICE | 2016-03-16 | — | — | CN | claimed |
| CN-105381844-A | Rotary tooth type material crushing device | XUZHOU INST TECHNOLOGY | 2016-03-09 | — | — | CN | claimed |
| CN-105368432-A | Pour point depressant for crude oil, preparation method for pour point depressant and application of pour point depressant | XUZHOU INST TECHNOLOGY | 2016-03-02 | — | — | CN | claimed |
| US-20120070825-A1 | Novel Compounds and Derivatizations of DNAs and RNAs on the Nucleobases of Pyrimidines for Function, Structure and Therapeutics | SENA RESEARCH, INC. (US) | 2012-03-22 | — | — | US | claimed |
| WO-2010135564-A2 | NOVEL COMPOUNDS AND DERIVATIZATION OF DNAS AND RNAS ON THE NUCLEOBASES OF PYRIMIDINES FOR FUNCTION, STRUCTURE, AND THERAPEUTICS | SENA RESEARCH, INC. (US) | 2010-11-25 | — | — | WO | claimed |
| JP-2003520042-A | — | — | 2003-07-02 | — | — | JP | claimed |
| EP-1250157-A1 | ANTISENSE MODULATION OF INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-10-23 | — | — | EP | claimed |
| WO-2001052902-A1 | ANTISENSE MODULATION OF INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2001-07-26 | — | — | WO | claimed |
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4707393-A1 | DOUBLE-STRANDED SIRNA, CONJUGATE THEREOF AND USE THEREOF | CMS Research & Development Pte. Ltd. (SG) | 2026-03-11 | — | — | EP | disclosed |
| EP-4678646-A1 | NUCLEOSIDE ANALOG FOR 5'-PHOSPHONATE MODIFICATION AND OLIGONUCLEOTIDE PREPARED THEREFROM | Shanghai Argo Biopharmaceutical Co., Ltd. (CN) | 2026-01-14 | — | — | EP | disclosed |
| EP-0333832-B1 | ARTIFICIAL DNA BASE PAIR ANALOGUES | TEMPLE UNIVERSITY (US) | 1992-06-03 | — | — | EP | disclosed |
| EP-0194545-B1 | LABELLING OF OLIGONUCLEOTIDES | MOLECULAR DIAGNOSTICS, INC. (US) | 1989-12-06 | — | — | EP | disclosed |
| US-4808520-A | HYBRIDIZING WITH NUCLEIC ACID, THEN WITH NUCLEOSIDE TRIPHOSPHATE IN PRESENCE OF ENZYME | MOLECULAR DIAGNOSTICS, INC. (US) | 1989-02-28 | — | — | US | disclosed |
| EP-0194545-A2 | Labelling of oligonucleotides | MOLECULAR DIAGNOSTICS, INC. (US) | 1986-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | PAICS, COASY, CDS2 | TSHR 2895/4885 |
| US-20120070825-A1 | Novel Compounds and Derivatizations of DNAs and RNAs on the Nucleobases of Pyrimidines for Function, Structure and Therapeutics | NSUN2, RNMT, TRDMT1 | TSHR 2373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.